EUVIMEDEUVIMED entdecken
Crossref

LACTB2 Promotes the Growth and Migration of Non‐Small Cell Lung Cancer By Regulating Mitochondrial Function

Jie Zhang, Qian Chen, Yuanyuan Wu, Yajing Han, Yong Li iD

Molecular Carcinogenesis · 2026-12 · 65 (12) · 1556-1568

DOI: 10.1002/mc.70180 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Carcinogenesis, online erschienen am 15.09.2026. Verfasst von Jie Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences and Medical Engineering, Anhui University, Hefei, Anhui Province, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Mitochondria, beta-Lactamases. Die Arbeit nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China., National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer remains one of the most commonly diagnosed cancers and the leading cause of cancer‐related mortality worldwide. As a mitochondrial matrix protein, the role of β‐lactamase‐like protein 2 (LACTB2) is unclear in non‐small cell lung cancer (NSCLC). In this study, we show that LACTB2 expression enhances the cell viability, anchorage‐independent growth, migration and epithelial‐mesenchymal transition(EMT) of NSCLC cells. Mechanistically, LACTB2 binds to mitochondrial DNA (mtDNA) and activates mitochondrial RNA (mtRNA) expression. Silencing LACTB2 induces mitochondrial dysfunction, which correlates with impaired proliferation, migration, and EMT in NSCLC cells. Furthermore, depletion of LACTB2 results in an increased expression of p53 and cleaved‐PARP, indicating that LACTB2‐mediated mitochondrial dysfunction activates the mitochondrial retrograde signaling‐p53 pathway to regulate apoptosis in A549 cells. Additionally, we found that high LACTB2 expression is statistically correlated with poor overall survival in NSCLC patients, and silencing LACTB2 inhibits tumor growth in xenograft mouse models. In summary, our findings reveal that LACTB2 plays a critical role in NSCLC progression by modulating mtRNA expression and mitochondrial function. Therefore, the LACTB2‐mtDNA‐mitochondrial dysfunction axis may serve as a novel target for diagnosis and treatment of NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsMitochondriabeta-LactamasesHumansAnimalsCell MovementCell ProliferationMiceGene Expression Regulation, NeoplasticApoptosisEpithelial-Mesenchymal TransitionDNA, MitochondrialRNA, MitochondrialTumor Suppressor Protein p53Cell Line, TumorFemaleMice, NudeA549 CellsMembrane ProteinsMitochondrial Proteins

Stichwörter der Autor:innen

LACTB2NSCLCgrowthmigrationmitochondrial dysfunction

Substanzen

LACTB protein, humanbeta-LactamasesDNA, MitochondrialRNA, MitochondrialTumor Suppressor Protein p53Membrane ProteinsMitochondrial Proteins

Autor:innen und Institutionen

  • School of Life Sciences and Medical Engineering, Anhui University, Hefei, Anhui Province, China.

ORCID-Profile: Yong Li

Förderung

  • National Natural Science Foundation of China.
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, J., Chen, Q., Wu, Y., Han, Y., & Li, Y. (2026). LACTB2 Promotes the Growth and Migration of Non‐Small Cell Lung Cancer By Regulating Mitochondrial Function. Molecular Carcinogenesis, 65(12), 1556-1568. https://doi.org/10.1002/mc.70180

Vancouver

Zhang J, Chen Q, Wu Y, Han Y, Li Y. LACTB2 Promotes the Growth and Migration of Non‐Small Cell Lung Cancer By Regulating Mitochondrial Function. Molecular Carcinogenesis. 2026;65(12):1556-1568. doi:10.1002/mc.70180

BibTeX
@article{Zhang2026,
  author = {Zhang, Jie and Chen, Qian and Wu, Yuanyuan and Han, Yajing and Li, Yong},
  title = {LACTB2 Promotes the Growth and Migration of Non‐Small Cell Lung Cancer By Regulating Mitochondrial Function},
  journal = {Molecular Carcinogenesis},
  year = {2026},
  volume = {65},
  number = {12},
  pages = {1556--1568},
  doi = {10.1002/mc.70180}
}
Kostenlos starten →